MedTrace Logo

Clinical Evaluation of a New Viscoelastic for Cataract Surgery

NCT00972621 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2025-02-11

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the safety and effectiveness of a new opthalmic viscoelastic material for the use in cataract surgery. The new viscoelastic will be compared to a currently marketed viscoelastic material.

Conditions

  • Cataract

Interventions

DEVICE

Vitrax II

Viscoelastic administered via one or two vials as determined by cataract surgeon for maintenance of anterior chamber.

DEVICE

Viscoat

Currently marketed viscoelastic administered via one or two vials as determined by cataract surgeon for maintenance of anterior chamber..

Sponsors & Collaborators

  • Abbott Medical Optics

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00972621 on ClinicalTrials.gov